Showing results (431-440 of 5,804) with videos related to
Sort By:
Pageof 581
Drug Design, Development and Therapy|April 25, 2017
Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animalsYingxiao Li, Kai Chun Cheng, Chiang-Shan Niu, et al.Drug Design, Development and Therapy|April 25, 2017
Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanibTong Lin, Lan GongDrug Design, Development and Therapy|April 14, 2017
Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axisNan Zhang, Yanyang Liu, Yuyi Wang, et al.Drug Design, Development and Therapy|September 14, 2016
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovirHanan Polansky, Adrian Javaherian, Edan ItzkovitzDrug Design, Development and Therapy|September 14, 2016
Chloroquine improves left ventricle diastolic function in streptozotocin-induced diabetic miceXun Yuan, Yi-Chuan Xiao, Gui-Ping Zhang, et al.Drug Design, Development and Therapy|September 24, 2016
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transitionDa-Jin Chen, Wei Chen, Hong Jiang, et al.Drug Design, Development and Therapy|May 2, 2018
Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK-mTOR pathwayShaoren Zhang, Yuqing Mao, Xiaoming FanDrug Design, Development and Therapy|July 24, 2018
Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysisHonggang Cheng, Aixia Sun, Qingbo Guo, et al.Drug Design, Development and Therapy|August 14, 2018
Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional surveyJames Ds Jackson, Sarah E Cotton, Sara Bruce Wirta, et al.Drug Design, Development and Therapy|May 30, 2017
Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trialXiao Hu, Fang Tan, Lan GongPageof 581